Wealth First Portfolio Managers FY26 sales up 29%

The headline numbers investors focused on

Wealth First Portfolio Managers reported a sharp recovery in the quarter ended March 2026, with sales reported at ₹16.51 crore and net profit at ₹10.52 crore. The same source set also described the quarter as a reversal from a net loss of ₹4.29 crore in the previous year period. A key complication in interpreting year-on-year performance is that the base quarter (Q4 FY25) included an unusual negative sales figure of ₹-3.26 crore, which multiple excerpts flagged as an anomaly. Even with that caveat, the reported swing from negative revenue to positive revenue made the latest quarter stand out in the company’s recent financial history.

Q4 FY26: sales jump and profitability rebound

The quarterly recovery was described as being driven by a 154.39% sequential jump in net sales to ₹16.51 crore. In the same context, operating margins were cited at 71.17% (another table snippet showed 63.54% for Mar’26). Net profit for Q4 FY26 was also stated as ₹104.87 million, which is ₹10.49 crore, reversing a net loss of ₹42.95 million or ₹4.30 crore in Q4 FY25. The revenue from operations was stated at ₹165.08 million or ₹16.51 crore, compared with ₹-32.64 million or ₹-3.26 crore in Q4 FY25.

The excerpts also carried a note of caution, calling the sustainability of the quarterly performance “questionable” given an erratic track record. That framing largely stems from the unusual negative revenue print in Q4 FY25 and the sharp quarter-to-quarter variability.

Understanding the negative sales base effect

Several lines in the provided material highlight that Q4 FY25’s negative sales number was “an anomaly in the company's financial history.” Because Q4 FY25 revenue was reported at ₹-3.26 crore, standard year-on-year percentage growth rates become distorted. One excerpt even described the year-on-year revenue change as a decline of 606.44% due to the unusual negative base.

For readers, the key takeaway is that Q4 FY26’s improvement is clear in absolute terms (sales of ₹16.51 crore and profit of about ₹10.5 crore), but percentage changes around a negative base can mislead. A cleaner comparison in this dataset is the sequential movement from Q3 FY26 to Q4 FY26, where Q3 FY26 net sales were referenced at ₹6.49 crore.

FY26: sales rise to ₹68.39 crore, profit up 13%

For the full year ended March 2026, sales were reported to have risen 28.65% to ₹68.39 crore, from ₹53.16 crore in the year ended March 2025. Net profit for the year was reported at ₹38.66 crore, up 13.21% from ₹34.15 crore a year earlier.

A separate consolidated snapshot in the text reported full-year FY26 net profit of ₹382.83 million (₹38.28 crore) versus ₹341.45 million (₹34.15 crore) in FY25, and total income of ₹710.89 million (₹71.09 crore) versus ₹600.67 million (₹60.07 crore). The net profit figures are broadly consistent across the two presentations, while “total income” is a different line item from “sales” and was not presented alongside the ₹68.39 crore sales figure in the same excerpt.

Management commentary: operations growth and insurance push

In the transcript-style portion of the material, “revenue from operations” was described as growing 28.7%, increasing from ₹53.2 crore in FY25 to ₹68.4 crore in FY26. This aligns closely with the separate sales line of ₹53.16 crore in FY25 and ₹68.39 crore in FY26.

The same commentary attributed growth to momentum across core operations, supported by insurance and steady net sales performance. It also noted that the company obtained its insurance license in the second quarter of FY26. Management expectation for the insurance segment was described repeatedly as a growth range of around 20% to 25%, with traction expected to pick up in FY28.

Client additions and business activity income

The material also referenced the addition of 311 new client families during the year. In another excerpt, an investor presentation for Q3 FY26 was cited as showing “business activity income” growing 7.8% year-on-year to ₹48.8 crore over nine months. The same presentation highlighted a trail-based revenue model and claimed a five-year CAGR of 29.2%.

These operating details matter because they help explain why revenue can be volatile quarter-to-quarter while still showing growth over a full year. They also provide context for the company’s focus on recurring or trail-linked income streams, alongside a newer insurance-led contribution.

Stock price context: below the 52-week high

The stock was described as trading at ₹982.65, down 31.76% from its 52-week high of ₹1,440.00, while up 42.37% from its 52-week low of ₹690.20. Another line stated the share price stood at ₹910.55 at the close of the market (date not specified in the excerpt). Together, these figures suggest the market has seen a wide trading range over the year, even as FY26 showed higher full-year sales and improved profitability.

Key figures snapshot (as stated)

An additional sales turnover table in the source

The provided material also included a standalone row labeled “Net Sales Turnover” with values: 63.40, 52.05, 53.85, 29.05, 31.17 (units and periods were not specified in the excerpt). Because the periods were not labeled, these figures are best read as an incomplete reference point rather than a reconciled time series.

What investors will likely track next

Two items in the material stand out as forward-looking, without requiring assumptions. First is the insurance segment ramp-up, where management expectations were stated as 20% to 25% growth and a traction pickup around FY28. Second is whether the company can maintain positive and stable quarterly revenue after the unusual negative revenue base seen in Q4 FY25.

For market participants, upcoming results will help clarify whether Q4 FY26 was a one-off spike or the start of a steadier run-rate, especially as insurance contribution scales post-licence. The consistency between “sales” reporting and the consolidated “total income” line will also matter for readers comparing different summaries.

Conclusion

Wealth First Portfolio Managers ended FY26 with reported sales of ₹68.39 crore, up 28.65%, and full-year profit growth to about ₹38.3-₹38.7 crore, while Q4 FY26 showed a notable rebound to ₹16.51 crore sales and roughly ₹10.5 crore profit. The company’s commentary points to insurance as an important growth lever after receiving its licence in Q2 FY26, with 20% to 25% segment growth expectations repeated in the provided transcript. The next few quarters should provide clearer evidence on whether revenue and profit can remain stable after a period marked by unusually volatile quarterly prints.